0001485003-19-000042.txt : 20190621
0001485003-19-000042.hdr.sgml : 20190621
20190621161516
ACCESSION NUMBER: 0001485003-19-000042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190619
FILED AS OF DATE: 20190621
DATE AS OF CHANGE: 20190621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DIXON WENDY L
CENTRAL INDEX KEY: 0001202283
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 19911687
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sesen Bio, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-444-8550
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc.
DATE OF NAME CHANGE: 20100223
4
1
wf-form4_156114810117022.xml
FORM 4
X0306
4
2019-06-19
0
0001485003
Sesen Bio, Inc.
SESN
0001202283
DIXON WENDY L
C/O SESEN BIO, INC.
245 FIRST STREET, SUITE 1800
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option
1.48
2019-06-19
4
A
0
105000
0
A
2029-06-18
Common Stock
105000.0
105000
D
The option was granted on June 19, 2019 and vests over one year, with 1/12th of the shares subject to the option vesting at the end of each successive one-month period following the grant date until the earlier of a) the day that is one business day prior to the date of the next annual meeting and b) the first anniversary of the grant date, at which time such option shall be fully vested.
/s/ Richard F. Fitzgerald as attorney-in-fact
2019-06-21